Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 2, 2010, Pages 150-154

  Varkey, Basil ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Opioids

Indexed keywords

CODEINE; DIAMORPHINE; FENTANYL; MORPHINE; OPIATE DERIVATIVE; OXYCODONE; OXYMORPHONE;

ALLERGIC REACTION; ALLERGY; ANAPHYLAXIS; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSTIPATION; COUGHING; DELIRIUM; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPNEA; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTENSION; LETHARGY; MYOCLONUS; NAUSEA; NEBULIZATION; OPIATE ADDICTION; PALLIATIVE THERAPY; PRURITUS; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; URINE RETENTION; URTICARIA; VOMITING;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; DYSPNEA; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 76449114846     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283364378     Document Type: Review

References (34)

1. Elkington H, White P, Addington-Hall J, et al. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med 2005; 19:485-491.
2. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease: a comparison of palliative care and quality of care in COPD and lung cancer. Thorax 2000; 55:1000-1006.
3. American Thoracic Society. Dyspnea: mechanisms, assessment and management - a consensus statement. Am J Respir Crit Care Med 1999; 159:321-340.
4. Pattinson KTS, Governs RJ, MacIntosh BJ, et al. Opioids depress cortical centers responsible for the volitional control of respiration. J Neurosci 2009; 29:8177-8186.
5. Peiffer C, Poline J, Thivard L, et al. Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med 2001; 163:951-957.
6. Mahler DA, Murray JA, Watoman LA, et al. Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J 2009; 33:771-777.
7. Jennings AL, Davies AN, Higgins JPT, Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database System Rev 2001:CD002066.
8. Abernathy AP, Currow DC, Firth P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003; 327:523-528.
9. Bruera E, MacEachern T, Ripamonti C, et al. Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 1993; 119:906-909.
10. Allard P, Lamontagne C, Bernard P, et al. How effective are supplementary doses of opioids for dyspnea in terminally-ill cancer patients? A randomized continuous sequential trial. J Pain Symptom Manage 1999; 17: 256-265.
11. Allen S, Raut S, Woolard J, Vassallo M. Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliat Med 2005; 19:128-130.
12. Zebraski SE, Kochenesh SM, Raffa B. Lung opioid receptors: pharmacology and possible target for nebulised morphine in dyspnea. Life Sci 2000; 66:221-231.
13. Masood AR, Thomas SH. Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects. Br J Clin Pharmacol 1996; 41:250-325.
14. Polosa R, Simidchiev A, Walters EH. Nebulised morphine for severe interstitial lung disease. Cochrane Database System Rev 2002: CD002872.
15. Harris-Eze AO, Sridhar G, Clements RE, et al. Low-dose nebulized morphine does not improve exercise in interstitial lung disease. Am J Respir Crit Care Med 1995; 152:1940-1945.
16. Young IH, Daviskas E, Keena VA. Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease. Thorax 1989; 44:387-390.
17. Masood AR, Reed JW, Thomas SH. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax 1995; 50:629-634.
18. Beauford W, Saylor TT, Stansbury DW, et al. Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient. Chest 1993; 104:175-178.
19. Jankelson D, Hosseini K, Mather LE, et al. Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease. Eur Respir J 1997; 10:2270-2274.
20. Noseda A, Carpiaux JP, Markstein C, et al. Disabling dyspnea in patients with advanced disease. Eur Respir J 1997; 10:1079-1083.
21. Farncombe M, Chater S. Case studies outlining use of nebulized morphine for end-stage chronic lung and heart disease. J Pain Symptom Manage 1993; 8:221-225.
22. Quelch PC, Faulkner DE, Yun JWS. Nebulized opioids in the treatment of dyspnea. J Palliat Care 1997; 13:48-52.
23. Janahi IA, Maciejewski SR, Teran JM, et al. Inhaled morphine to relieve dyspnea in advanced cystic fibrosis in lung disease. Pediatr Pulmonol 2000; 30:257-259.
24. Cohen SP, Dawson T. Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis. Pediatrics 2002; 110:38-40.
25. Graff GR, Stark JM, Grueber R. Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient. Respiration 2004; 71:646-649.
26. Hallenbeck J, Gauna AA, Kang SK, et al. Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational series. J Palliat Med 2008; 643-648.
27. Hanks G, Cherny NI, Fallon M. Opioid analgesic therapy. In: Doyle D, Hanks G, Cherny N, Calman K, editors. Oxford textbook of palliative medicine. Oxford, UK: Oxford University Press; 2004. pp. 316-342.
28. Thomas JR, von Gunten CF. Clinical management of dyspnoea. Lancet Oncol 2002; 3:223-228.
29. Woodcock AA, Johnson MA, Geddes DM. Breathlessness, alcohol and opiates. N Engl J Med 1982; 306:1363-1364.
30. Chandler S. Nebulized opioids to treat dyspnea. Am J Hospice Palliat Care 1999; 16:418-422.
31. Lang E, Jedeikin R. Acute respiratory depression as a complication of nebulized morphine. Can J Anaesth 1998; 45:60-62.
32. Woodall HE, Chiu A, Weissman DE. Opioid allergic reactions. Fast Fact and Concept #175; 2007. www.eperc.mcw.edu.
33. McCaffery M. Pain control. Barriers to the use of available information. World Health Organization Expert Committee on Cancer Pain Relief and Active Supportive Care. Cancer 1992; 70 (Suppl 5):1438-1449.
34. Schug SA, Zech D, Grond S, et al. A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage 1992; 7:259-266.